Physician profile
Fred R Defrancesch
NPI 1558460261
$10,573.29
in general payments reported to CMS, 2019-2025
46 companies · $951 in 2025
The $951 reported for 2025 was more than what 87% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,677 · 2020: $1,299 · 2021: $1,674 · 2022: $878 · 2023: $1,408 · 2024: $1,687 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,323 · Travel and Lodging: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.39 |
| Travel and Lodging | $722.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,419.95 | 2019-2025 | Relistor, Aldara |
| Vertiflex, INC. | $1,326.45 | 2019 | |
| Boston Scientific Corporation | $1,173.71 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $836.46 | 2019-2024 | Belbuca, Xtampza |
| Ibsa Pharma INC. | $459.69 | 2021-2025 | Tirosint, Tirosint, Licart |
| Forte Bio-Pharma LLC | $454.65 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Relievant Medsystems, INC. | $439.12 | 2022-2023 | Intracept |
| Abbott Laboratories | $422.83 | 2020-2022 | |
| Nevro Corp. | $385.76 | 2019-2024 | Senza |
| Amgen INC. | $326.06 | 2019-2024 | Krystexxa |
| Pfizer INC. | $307.31 | 2019-2025 | |
| Abbvie INC. | $279.40 | 2021-2025 | Qulipta, Ubrelvy |
| Globus Medical, INC. | $275.24 | 2025 | Senza, Omnia, Vyrsa V1 |
| Almatica Pharma LLC | $208.12 | 2021-2023 | Gralise |
| Medtronic, INC. | $195.23 | 2021-2024 | Intellis Adaptivestim |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Defrancesch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.